Fluoroquinolone structure and translocation flux across bacterial membrane

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  J. Pagés,et al.  Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective , 2017, Expert opinion on drug metabolism & toxicology.

[3]  J. Pagés,et al.  Erratum: Unusual marine unicellular symbiosis with the nitrogen-fixing cyanobacterium UCYN-A , 2017, Nature Microbiology.

[4]  M. Postma,et al.  The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship , 2017, Intensive Care Medicine.

[5]  M. Falagas,et al.  Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis. , 2017, International journal of antimicrobial agents.

[6]  M. Pucci,et al.  Treatment of Gram-negative bacterial infections by potentiation of antibiotics. , 2016, Current opinion in microbiology.

[7]  M. Cooper,et al.  Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coli , 2016, ACS infectious diseases.

[8]  L. Piddock,et al.  How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps , 2016, mBio.

[9]  R. Bonomo,et al.  Overview: Global and Local Impact of Antibiotic Resistance. , 2016, Infectious disease clinics of North America.

[10]  R. Laxminarayan,et al.  Access to effective antimicrobials: a worldwide challenge , 2016, The Lancet.

[11]  B. Cinquin,et al.  Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level , 2015, Scientific Reports.

[12]  S Gnanakaran,et al.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. , 2015, ACS infectious diseases.

[13]  P. Carey,et al.  New techniques in antibiotic discovery and resistance: Raman spectroscopy , 2015, Annals of the New York Academy of Sciences.

[14]  Keith D. Morrison,et al.  Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli , 2015, Journal of bacteriology.

[15]  Daniel H. Foil,et al.  A Mass Spectrometry-Based Assay for Improved Quantitative Measurements of Efflux Pump Inhibition , 2015, PloS one.

[16]  S. Tentarelli,et al.  Thinking outside the "bug": a unique assay to measure intracellular drug penetration in gram-negative bacteria. , 2015, Analytical chemistry.

[17]  Hiroshi Nikaido,et al.  The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria , 2015, Clinical Microbiology Reviews.

[18]  M. Webber,et al.  Molecular mechanisms of antibiotic resistance , 2014, Nature Reviews Microbiology.

[19]  Jessica M. A. Blair,et al.  Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. , 2014, Future microbiology.

[20]  Derek S. Tan,et al.  General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria , 2014, ACS chemical biology.

[21]  M. Winterhalter,et al.  TRANSLOCATION Project: How to Get Good Drugs into Bad Bugs , 2014, Science Translational Medicine.

[22]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[23]  J. Pagés,et al.  Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution , 2012, PloS one.

[24]  H. Nikaido,et al.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. , 2012, FEMS microbiology reviews.

[25]  J. Handzlik,et al.  Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria , 2011, FEBS letters.

[26]  Daniel Jones.  The antibacterial lead discovery challenge: a recent report provides a rare example of a potential new class of antibiotics. Dan Jones investigates the difficulties of finding such drugs , 2010 .

[27]  Nico Stuurman,et al.  Computer Control of Microscopes Using µManager , 2010, Current protocols in molecular biology.

[28]  Frank Wien,et al.  Synchrotron UV Fluorescence Microscopy Uncovers New Probes in Cells and Tissues , 2010, Microscopy and Microanalysis.

[29]  T. Meinnel,et al.  New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors , 2009, PloS one.

[30]  M. Winterhalter,et al.  The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria , 2008, Nature Reviews Microbiology.

[31]  J. Pagés,et al.  Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. , 2008, Current drug targets.

[32]  H. Nikaido.  Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[33]  H. Nikaido,et al.  Prevention of drug access to bacterial targets: permeability barriers and active efflux. , 1994, Science.

[34]  D. W. O. HEDDLE,et al.  Raman Spectroscopy , 1967, Nature.